e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Acute respiratory failure, ARDS and severe COPD exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Natriuretic peptide as a prognostic biomarker in septic shock in respiratory intensive care
C. Lopes, S. Carvalho, E. Fragoso, P. Azevedo, J. Monteiro, F. Monteiro, C. Bárbara (Lisbon, Portugal)
Source:
Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Session:
Acute respiratory failure, ARDS and severe COPD exacerbations
Session type:
Thematic Poster Session
Number:
2435
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Lopes, S. Carvalho, E. Fragoso, P. Azevedo, J. Monteiro, F. Monteiro, C. Bárbara (Lisbon, Portugal). Natriuretic peptide as a prognostic biomarker in septic shock in respiratory intensive care. Eur Respir J 2013; 42: Suppl. 57, 2435
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Usefulness of procalcitonin as a predictor for bacteremia and prognosis in severe sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
Level of adrenomedullin in cases with adrenal aefficiency and its relation to mortality in patients with sepsis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
Prognostic power of biomarkers to predict in-hospital and postdischarge mortality in community acquired pneumonia
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013
Individual monitoring of procalcitonin and C-reactive protein levels as a criterion for cancel of antibiotic therapy in patients with severe community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Physiological score SIPF (shock index and hypoxemia) is an accurate predictor of ICU admission in community-acquired pneumonia
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Characterization and identification of novel serum miRNAs in sepsis patients with different outcomes
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Procalcitonin as etiological marker of severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Disseminated intravascular coagulation profiles in patients with septic shock on ECMO
Source: International Congress 2016 – Diagnostic and therapeutic challenges in acute respiratory failure
Year: 2016
Could the early administration of antibiotics before admission improve the prognosis of pneumonia?
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Blood urea nitrogen/ albumin ratio: Is it a new predictor for prognosis of community-acquired pneumonia?
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)?
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
The prognostic value of consecutive C-reactive protein measurements in community acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Endothelial dysfunction and prognostic significance of endothelin-1 in patients with severe pneumonia and pulmonary sepsis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Risk factors for mortality in severe pneumonia patients followed in ICU
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
Assessment of severity of intensive care unit-acquired pneumonia and association with aetiology
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Hypercapnia as a marker of ICU admission and prolonged hospitalization in patients with community-acquired pneumonia
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015
Community-acquired pneumonia with severe sepsis: Etiology and prognosis
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Effectiveness of immune stimulatory therapy in patient with severe community-acquired pneumonia (CAP)
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept